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Abstract
Background
Severe anemia is a major cause of  sickness and death in African children, yet the causes of  anemia in this population have been 
inadequately studied.
Methods
We conducted a case–control study of  381 preschool children with severe anemia (hemoglobin concentration, <5.0 g per deciliter) and 
757 preschool children without severe anemia in urban and rural settings in Malawi. Causal factors previously associated with severe 
anemia were studied. The data were examined by multivariate analysis and structural equation modeling.
Results
Bacteremia (adjusted odds ratio, 5.3; 95% confidence interval [CI], 2.6 to 10.9), malaria (adjusted odds ratio, 2.3; 95% CI, 1.6 to 3.3), 
hookworm (adjusted odds ratio, 4.8; 95% CI, 2.0 to 11.8), human immunodeficiency virus infection (adjusted odds ratio, 2.0; 95% CI, 
1.0 to 3.8), the G6PD−202/−376 genetic disorder (adjusted odds ratio, 2.4; 95% CI, 1.3 to 4.4), vitamin A deficiency (adjusted odds ratio, 2.8; 
95% CI, 1.3 to 5.8), and vitamin B12 deficiency (adjusted odds ratio, 2.2; 95% CI, 1.4 to 3.6) were associated with severe anemia. Folate 
deficiency, sickle cell disease, and laboratory signs of  an abnormal inflammatory response were uncommon. Iron deficiency was not 
prevalent in case patients (adjusted odds ratio, 0.37; 95% CI, 0.22 to 0.60) and was negatively associated with bacteremia. Malaria was 
associated with severe anemia in the urban site (with seasonal transmission) but not in the rural site (where malaria was holoendemic). 
Seventy-six percent of  hookworm infections were found in children under 2 years of  age.
Conclusions
There are multiple causes of  severe anemia in Malawian preschool children, but folate and iron deficiencies are not prominent among 
them. Even in the presence of  malaria parasites, additional or alternative causes of  severe anemia should be considered.
Introduction
Severe anemia (hemoglobin concentration less than 5.0 g 
per deciliter) is a major cause of  sickness and death among 
children in sub-Saharan Africa.1-4 In various settings, 12 to 
29% of  hospitalized children are severely anemic,1-4 and the 
in-hospital case fatality rate in these children is 8 to 17%.1,3,4 
Little is known about the causes of  severe anemia in African 
children. Most studies have been confined to the anemia 
associated with malaria5 or with other individual factors.1,2,6 
As a result, the treatment guidelines advocated by the World 
Health Organization (WHO) deal specifically with malaria, 
folate deficiency, and iron deficiency, which are widely held 
to be the most common causes of  severe anemia in African 
children.7 To improve our understanding of  severe anemia, 
we conducted a case–control study in Malawi to assess the 
causative factors in Malawian children with severe anemia.
Methods
Study sites
We conducted the study in Malawi at Chikwawa District 
Hospital in a rural area where malaria infections occur 
throughout the year (approximately 170 infectious bites per 
person per year) and at Queen Elizabeth Central Hospital, a 
referral hospital in urban Blantyre, where malaria is seasonal, 
largely coinciding with the rainy season (approximately 1 
infectious bite per person per year) (Mzilahowa T: personal 
communication). Predefined catchment areas were used; the 
urban area was confined to the city limits.
Study design
Between July 2002 and July 2004, a consecutive sample of  
children (382 case patients) who presented at the outpatient 
department during working hours with a primary diagnosis 
of  severe anemia (defined as a hemoglobin concentration 
of  <5.0 g per deciliter) were recruited into a prospective 
case–control study. Additional inclusion criteria were an age 
between 6 and 60 months and no blood transfusion within 
the previous 4 weeks.
For each case patient, a community control patient and a 
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hospital control patient were enrolled. Community control 
patients were recruited from apparently healthy residents 
living within 100 to 1000 m of  the case patient; hospital 
control patients were recruited by selecting the first child 
presenting at the outpatient department at the same time on 
the next working day after presentation of  the case patient. 
Community and hospital control patients were eligible for 
recruitment if  their hemoglobin level was at least 5.0 g per 
deciliter and they were between 6 and 60 months of  age; 
no other matching was applied. Written informed consent 
was obtained from a parent or a guardian of  each child in 
all three study groups. The study was approved by the ethics 
committees of  the College of  Medicine, Malawi, and the 
Liverpool School of  Tropical Medicine, United Kingdom.
Clinical assessment and management
On enrollment, a clinical research form, including a medical 
and dietary history, sociodemographic data, and physical 
examination, was completed, and samples of  blood, urine, 
and stool were collected. In case patients, if  the clinical 
condition permitted it, a bone marrow aspirate was obtained 
under local anesthesia. Children requiring admission were 
treated in a study ward. All conditions were managed 
according to standard protocols.
Anthropometric measurements
Nutritional z scores were calculated according to the WHO 
growth reference curves8 with the use of  Epi Info 2000. 
Weight-for-height, height-for-age, and weight-for-age z 
scores of  less than −2 were considered to indicate wasting, 
stunting, and underweight, respectively; z scores of  less 
than −3 were considered to indicate severe wasting, severe 
stunting, or severe underweight.
Laboratory methods
Laboratory tests (hematologic, bacteriologic, and 
parasitologic) were performed within 24 hours after 
collection, and aliquots were stored at −80°C for later 
analysis. The laboratory staff  were unaware of  the children’s 
study groups.
Hematologic studies
Hemoglobin concentration was measured on site with 
a HemoCue system. A complete blood count, including 
reticulocytes, was performed by a Coulter counter. In case 
patients, bone marrow slides were stained with Hematognost 
Fe (Merck) and graded for iron content9; these results were 
used to validate peripheral blood markers of  iron deficiency. 
The ratio of  soluble transferrin receptor to log ferritin (TfR-F 
index)10 best predicted bone marrow iron status, irrespective 
of  the presence of  infection; a TfR-F index greater than 5.6 
was used to define iron deficiency with a sensitivity of  70% 
and a specificity of  75% (unpublished data).
Chemical studies
Plasma levels of  C-reactive protein, haptoglobin, transferrin, 
iron, ferritin, folate, and vitamin B12 were analyzed on 
Modular P800 and Modular Analytics E170 systems 
(Roche). Inflammatory cytokine profiles were measured by 
Cytometric Bead Array on a FACSCalibur flow cytometer 
(Becton Dickinson). Serum vitamin A (retinol) and soluble 
transferrin receptor were measured by high-performance 
liquid chromatography11 and enzyme-linked immunosorbent 
assay, respectively.
Parasitologic Studies
The number of  Plasmodium falciparum asexual parasites per 
200 white cells was counted and expressed as the number 
per microliter of  blood. Malaria slides were read by two 
independent readers, with a third being used if  the results 
differed by more than 25%. Malaria was defined by the 
presence of  P. falciparum asexual parasites. Recent or current 
malaria was defined by the presence of  P. falciparum asexual 
parasites in erythrocytes or malaria pigment in monocytes 
or macrophages.12 Hyperparasitemia was defined as more 
than 100,000 parasites per microliter.2 Stool samples were 
examined for helminths by the Kato–Katz method.13 Heavy 
hookworm infection was defined by the presence of  more 
than 1000 ova per gram of  feces. A polymerase-chain-
reaction (PCR) test was used to confirm the microscopical 
results and define the species (Ancylostoma duodenale or Necator 
americanus).14 Urine specimens were examined for Schistosoma 
haematobium by a semiquantitative concentration method.15
Bacteriologic studies
A bone marrow or venous blood sample (1 to 2 ml) was 
inoculated into BACTEC Myco/F-Lytic culture vials and 
incubated in a BACTEC 9050 automated culture system 
(Becton Dickinson) for 56 days. Subculturing, susceptibility 
testing, and isolate identification were performed by standard 
techniques.16 Cultures were checked for mycobacteria with 
the use of  Ziehl–Neelsen staining of  smears. Mixed growths 
or growths of  micrococci, bacillus species, or coagulase-
negative staphylococci were considered contaminants.
Virologic studies
Whole-blood isolates17 were assessed for Epstein–Barr virus 
and cytomegalovirus infection by semiquantitative PCR18 
and for parvovirus by real-time PCR.19 Infections were 
considered clinically important if  the number of  viral copies 
exceeded 1000 per milliliter of  blood. Testing for human 
immunodeficiency virus (HIV) was performed by two rapid 
tests (Determine, Abbott Laboratories; and Uni-Gold, 
Trinity Biotech). Discordant or positive rapid-test results in 
children less than 18 months of  age were resolved by PCR.20
Genetic studies
DNA was extracted with a Nucleon extraction kit (Amersham 
Biosciences) and genotyped by primer-extension mass 
spectrometry with the use of  MassARRAY (Sequenom).21 
The presence of  sickle cell disease (homozygosity for 
hemoglobin S) and single-nucleotide polymorphisms in 
the promoter regions of  the genes encoding interleukin-10 
(IL10) (–1117, −3585, and +4949)21 and tumor necrosis 
factor (TNF) (−238, −308, and −1031)22 was determined. 
The term G6PD−202/−376 is used to denote boys who are 
hemizygous and girls who are homozygous for both the 
G6PD202A and the G6PD376G alleles, a condition that is 
strongly predictive of  glucose-6-phosphate dehydrogenase 
deficiency.23 The Hardy–Weinberg equilibrium was applied 
(cutoff, P<0.001), and there was no significant population 
stratification. We chose the allele frequency, dominant 
model, or haplotype that was most strongly associated with 
severe anemia.
Statistical analysis
The prevalence rates of  each factor were compared 
individually across the three groups with the use of  Fisher’s 
exact test and the chi-square test. The combined association 
of  characteristics related to the risk of  severe anemia 
(P≤0.10, unless the characteristics were uncommon [<5%]) 
was examined by an unconditional multivariate logistic-
regression model corrected for potential confounding 
http://dx.doi.org/10.1056/NEJMoa072727
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Hemoglobin levels differed significantly between the case 
patients and each of  the two control groups but were similar 
in the two control groups. Splenomegaly (in which >1 cm of  
the spleen was palpable) and severe splenomegaly (in which 
≥8 cm was palpable) were more common in case patients 
(P<0.001 and P = 0.03, respectively). Severe splenomegaly, 
which was present in 11 case patients (3.0%), was not 
associated with thrombocytopenia or leukopenia. Jaundice 
was more common in case patients (5.0%) but was not 
associated with sickle cell disease (P = 1.00), G6PD−202/−376 
(P = 0.70), or splenomegaly (P = 0.30). Twenty-four case 
patients (6.3%) died after admission to the hospital, nine 
(37.5%) before receiving a transfusion. We obtained samples 
of  peripheral blood from 1105 subjects (97.1%), stool from 
1024 subjects (90.0%), urine from 1042 subjects (91.6%), 
and bone marrow from 348 case patients (91.3%). Table 
2 lists the features we investigated in the three groups and 
gives the P values for differences among the groups. Factors 
significantly associated with severe anemia were further 
explored in a multivariate and structural equation model (Fig. 
1 and 2).
Malaria
P. falciparum was identified in 226 case patients (59.5%) 
and 321 control patients (42.8%) and was the predominant 
malarial species overall (97.5%). P. malariae was found in 
1.6% and a mixed infection in 0.9% of  the study patients. 
The attributable risk of  severe anemia associated with P. 
factors (age, sex, recent use [i.e., within the previous 8 
weeks] of  antimalarial or hematinic agents, and a history 
of  transfusions [i.e., before the previous 4 weeks]). Missing 
observations were included in the analysis by creating 
missing-value categories. Alternative definitions for malaria, 
hookworm, and nutritional deficiencies and status were 
tested. Attributable-risk percentages were calculated with the 
use of  adjusted odds ratios.24 The primary analysis compared 
all case patients with the two control groups combined. To 
explore the possibility that different patient characteristics 
were important in the two study locations, secondary analyses 
were performed with stratification according to location and 
with the community and hospital control groups separated. 
More complex associations and alternative strategies for 
handling missing data (e.g., maximum-likelihood imputation) 
were explored by structural equation modeling.25 All reported 
P values are two-sided. The data were analyzed with the use 
of  Stata (version 9), SPSS (version 12), and Amos (version 
6.0) software.
Results
We enrolled 1141 children over a 2-year period. Five protocol 
violations occurred: two hospital control children had severe 
anemia and were redesignated as case patients, one case 
patient with a hemoglobin concentration of  more than 5.0 
g per deciliter was excluded, and two control patients under 
6 months of  age were excluded. Table 1 summarizes the 
characteristics of  the 1138 children included in the analysis. 
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tus were tested. Attributable-risk percentages were 
calculated with the use of adjusted odds ratios.24 
The primary analysis compared all case patients 
with the two control groups combined. To explore 
the possibility that different patient characteris-
tics were important in the two study locations, 
secondary analyses were performed with stratifi-
cation according to location and with the com-
munity and hospital control groups separated. 
More complex associations and alternative strat-
egies for handling missing data (e.g., maximum-
likelihood imputation) were explored by structural 
equation modeling.25 All reported P values are 
t o-sided. The data ere analyzed with the use 
of Stata (version 9), SPSS (version 12), and Amos 
(version 6.0) software.
Results
We enrolled 1141 children over a 2-year period. Five 
protocol violations occurred: two hospital control 
children had severe anemia and were redesignat-
ed as case patients, one case patient with a hemo-
globin concentration of more than 5.0 g per deci-
liter was excluded, and two control patients under 
6 months of age were excluded. Table 1 summa-
rizes the characteristics of the 1138 children in-
cluded in the analysis. Hemoglobin levels differed 
significantly between the case patients and each 
of the two control groups but were similar in t  
two control groups. Splenomegaly (in which >1 cm 
of the spleen was palpable) and severe splenomeg-
aly (in which ≥8 cm was palpabl ) were more com-
Table 1. Characteristics of the Study Groups.*
Characteristic
Case Patients  
(N = 381)
Community Control 
Patients  
(N = 380)
Hospital Control  
Patients  
(N = 377)
Area — no. (%)†
Urban 205 (53.8) 203 (53.4) 201 (53.3)
Rural 176 (46.2) 177 (46.6) 176 (46.7)
Sex — no. (%)
Female 203 (53.3) 191 (50.3) 180 (47.7)
Male 178 (46.7) 189 (49.7) 197 (52.3)
Age — mo‡ 20.4±12.8 25.3±13.1 22.5±12.1
Jaundice — no./total no. (%)§ 19/379 (5.0) 1/380 (0.3) 0/376
Splenomegaly — no./total no. (%)§¶ 237/372 (63.7) 108/363 (29.8) 86/349 (24.6)
Fever — no./total no. (%)‖** 189/376 (50.3) 41/375 (10.9) 172/374 (46.0)
Hemoglobin — g/dl§†† 3.6±0.8 9.9±1.9 9.6±2.2
Mean corpuscular volume — fl§‡‡ 82.9±15.2 75.5±9.3 74.2±9.7
Reticulocyte count — ×10−9/liter‡§§
Median 53.2 76.8 64.5 
Interquartile range 30.2–91.7 46.4–114.7 43.0–103.2
Admitted to hospital — no. (%)† 381 (100) 3 (0.8) 17 (4.5)
Died in hospital — no. (%)† 24 (6.3) 0 0
* Plus–minus values are means ±SD.
† No statistical tests were applied.
‡ P<0.05 for differences among all three groups (by Tukey post hoc test or Kruskal–Wallis test with Tukey multiple 
comparisons). 
§ Community and hospital control patients were significantly different from case patients (P<0.05 by Tukey post hoc test). 
Case patients had a primary diagnosis of severe anemia (defined as a hemoglobin concentration of <5.0 g per deciliter).
¶ Splenomegaly was defined as more than 1 cm of palpable spleen below the left costal margin in the midaxillary line.
‖ Community control patients were significantly different from case patients and hospital control patients (P<0.05 by 
Tukey post hoc test).
** Fever was defined as an axillary temperature of more than 37.5°C. 
†† Hemoglobin values were recorded in 373 community control patients and 375 hospital control patients.
‡‡ Mean corpuscular volume was recorded in 316 case patients, 322 community control patients, and 314 hospital con-
trol patients.
§§ Reticulocyte values were recorded in 266 case patients, 284 community control patients, and 279 hospital control patients.
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Table 2. Distribution of Possible Etiologic and Confounding Factors among Study Groups According to Recruitment Sites.*
Variable Both Sites Rural Site
Case Patients  
(N = 381)
Community  
and Hospital 
Control Patients  
(N = 757) P Value
Case Patients  
(N = 176)
Community 
Control Patients  
(N = 177) P Value
no./total no. (%) no./total no. (%)
History
Mother did not attend secondary 
school
323/366 (88.3) 554/753 (73.6) <0.001 162/172 (94.2) 154/176 (87.5) 0.03
Death of a parent 25/284 (8.8) 22/554 (4.0) 0.004 13/168 (7.7) 5/163 (3.1) 0.06
Recent hematinic treatment 85/376 (22.6) 61/754 (8.1) <0.001 40/176 (22.7) 7/177 (4.0) <0.001
Recent antimalarial treatment 232/375 (61.9) 346/755 (45.8) <0.001 107/176 (60.8) 79/177 (44.6) 0.002
History of transfusion 57/378 (15.1) 38/756 (5.0) <0.001 24/176 (13.6) 9/177 (5.1) 0.006
Malnutrition†
Wasting 52/330 (15.8) 43/695 (6.2) <0.001 24/169 (14.2) 9/174 (5.2) 0.005
Iron deficiency 97/208 (46.6) 288/415 (69.4) <0.001 71/101 (70.3) 76/95 (80.0) 0.12
Vitamin B12 deficiency 95/312 (30.4) 94/603 (15.6) <0.001 46/142 (32.4) 20/143 (14.0) <0.001
Vitamin A deficiency 228/247 (92.3) 172/262 (65.6) <0.001 113/126 (89.7) 44/83 (53.0) <0.001
Viral infections
HIV 45/357 (12.6) 41/682 (6.0) <0.001 7/176 (4.0) 5/176 (2.8) 0.56
Parvovirus B19 5/294 (1.7) 2/609 (0.3) 0.03 2/143 (1.4) 0/147 0.15
Epstein–Barr virus 89/269 (33.1) 102/566 (18.0) <0.001 43/128 (33.6) 34/133 (25.6) 0.16
Bacteremia 54/359 (15.0) 14/353 (4.0) <0.001 20/171 (11.7) ND
Parasitic infections
Plasmodium falciparum 226/380 (59.5) 321/750 (42.8) <0.001 91/176 (51.7) 93/175 (53.1) 0.79
Hyperparasitemic P. falciparum‡ 45/380 (11.8) 24/750 (3.2) <0.001 17/176 (9.7) 3/175 (1.7) 0.001
Recent or current P. falciparum 243/334 (72.8) 336/696 (48.3) <0.001 113/169 (66.9) 98/171 (57.3) 0.07
Hookworm 29/296 (9.8) 12/642 (1.9) <0.001 27/154 (17.5) 4/160 (2.5) <0.001
Schistosoma mansoni 2/296 (0.7) 8/643 (1.2) 0.43 2/154 (1.3) 4/160 (2.5) 0.44
S. haematobium 4/307 (1.3) 8/669 (1.2) 0.89 4/159 (2.5) 6/168 (3.6) 0.58
Genetic disorders§
G6PD −202/−376 44/318 (13.8) 54/601 (9.0) 0.02 21/152 (13.8) 11/141 (7.8) 0.10
Sickle cell disease 4/238 (1.7) 4/404 (1.0) 0.45 2/118 (1.7) 2/101 (2.0) 0.88
IL10 −1117 (C/C+C/T vs. T/T) 196/324 (60.5) 332/607 (54.7) 0.09 98/155 (63.2) 75/141 (53.2) 0.08
IL10 −3585 (A/A vs. A/T+T/T) 22/308 (7.1) 25/575 (4.3) 0.08 8/148 (5.4) 6/134 (4.5) 0.72
IL10 +4949 (G/G vs. G/A+A/A) 97/322 (30.1) 134/606 (22.1) 0.007 48/155 (31.0) 31/140 (22.1) 0.09
Abnormal ratio of interleukin-10 to 
TNF-α
4/276 (1.4) NA 1/122 (0.8) NA
* All P values are for the comparisons between case patients and community control patients, hospital control patients, or both. Among vari-
ables not included in the table (because they did not meet the preset cutoff for significance) are parental unemployment, household assets, 
folate deficiency, trichuriasis, ascariasis, cytomegalovirus infection, hemoglobin C, and tumor necrosis factor α (TNF-α) alleles or genotypes 
(−238, −308, and −1031). Recent is defined as within 8 weeks before recruitment. HIV denotes human immunodeficiency virus, IL10 the 
gene encoding interleukin-10, NA not available, and ND not done. G6PD−202/−376 denotes boys who are hemizygous and girls who are ho-
mozygous for both the G6PD202A and the G6PD376G alleles.
† Wasting is defined as a weight-for-height z score of less than −2. Iron deficiency is defined as a ratio of soluble transferrin receptor to log 
ferritin (TfR-F index)10 that is greater than 5.6 (unpublished data). Folate concentrations of less than 0.3 μg per deciliter (6.8 nmol per liter),  
vitamin B12 concentrations of less than 20 ng per deciliter (148 pmol per liter), and vitamin A concentrations of less than 20 μg per deciliter  
(0.7 μmol per liter) are considered to indicate deficiencies. 
‡ Hyperparasitemia is defined as more than 100,000 parasites per microliter of blood. 
§ The rs classifications for the genetic markers are as follows: IL10 −1117, rs1800896; IL10 −3585, rs1800890; IL10 +4949, rs3024500; TNF −238, 
rs361525; TNF −308, rs1800629; and TNF −1031, rs1799964. A ratio of interleukin-10 to TNF-α that is less than 1 is considered abnormal.22 
The New England Journal of Medicine 
Downloaded from nejm.org by Andrew Mataya on August 24, 2016. For personal use only. No other uses without permission. 
 Copyright © 2008 Massachusetts Medical Society. All rights reserved. 
falciparum was 33.5% overall and 47.3% in the urban setting. 
In the rural setting, a significant association between malaria 
and severe anemia was found only in the subgroup of  patients 
who had hyperparasitemia (9.7%) (adjusted odds ratio for 
case patients vs. community controls, 7.1; 95% confidence 
interval [CI], 1.4 to 34.6).
HIV
HIV infection was found in 86 children (12.6% of  case 
patients and 6.0% of  controls). The attributable risk of  
severe anemia associated with HIV was 6.2% overall and 
15.4% in the urban setting. Among severely anemic children, 
significantly more HIV-infected than HIV-uninfected children 
had Epstein–Barr virus infection (15 of  30 [50.0%] vs. 69 of  
226 [30.5%], P=0.03) or bacteremia (11 of  42 [26.2%] vs. 38 
of  300 [12.7%], P=0.02), whereas significantly fewer HIV-
infected than HIV-uninfected children had hyperparasitemia 
(2 of  44 [4.5%] vs. 42 of  312 [13.5%], P=0.09) or vitamin B12 
deficiency (5 of  39 [12.8%] vs. 85 of  254 [33.5%], P=0.009).
Bacteremia
Fifty-four case patients (15.0%) and 14 controls (4.0%) had 
bacteremia. The attributable risk of  severe anemia associated 
with bacteremia was 12.2%. The most common pathogen 
http://dx.doi.org/10.1056/NEJMoa072727
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mon in case patients (P<0.001 and P = 0.03, respec-
tively). Severe splenomegaly, which was present in 
11 case patients (3.0%), was not associated with 
thrombocytopenia or leukopenia. Jaundice was 
more common in case patients (5.0%) but was 
not associated with sickle cell disease (P = 1.00), 
G6PD−202/−376 (P = 0.70), or splenomegaly (P = 0.30). 
Twenty-four case patients (6.3%) died after admis-
sion to the hospital, nine (37.5%) before receiving 
a transfusion. We obtained samples of peripheral 
blood from 1105 subjects (97.1%), stool from 1024 
subjects (90.0%), urine from 1042 subjects (91.6%), 
and bone marrow from 348 case patients (91.3%). 
Table 2 lists the features we investigated in the 
three groups and gives the P values for differences 
among the groups. Factors significantly associated 
Rural Site Urban Site
Hospital Control 
Patients  
(N = 176) P Value
Case Patients  
(N = 205)
Community Control 
Patients  
(N = 203) P Value
Hospital Control 
Patients  
(N = 201) P Value
no./total no. (%) no./total no. (%) no./total no. (%)
143/176 (81.2) <0.001 161/194 (83.0) 142/200 (71.0) 0.005 115/201 (57.2) <0.001
3/164 (1.8) 0.01 12/116 (10.3) 6/109 (5.5) 0.18 8/118 (6.8) 0.33
13/176 (7.4) <0.001 45/200 (22.5) 19/202 (9.4) <0.001 22/199 (11.1) 0.002
90/176 (51.1) 0.07 125/199 (62.8) 77/203 (37.9) <0.001 100/199 (50.3) 0.01
13/176 (7.4) 0.06 33/202 (16.3) 7/203 (3.4) <0.001 9/200 (4.5) <0.001
19/175 (10.9) 0.35 28/161 (17.4) 6/182 (3.3) <0.001 9/164 (5.5) <0.001
63/92 (68.5) 0.78 26/107 (24.3) 76/113 (67.3) <0.001 73/115 (63.5) <0.001
30/149 (20.1) 0.02 49/170 (28.8) 24/157 (15.3) 0.003 20/154 (13.0) <0.001
60/74 (81.1) 0.09 115/121 (95.0) 32/60 (53.3) <0.001 36/45 (80.0) 0.003
9/172 (5.2) 0.58 38/181 (21.0) 9/171 (5.3) <0.001 18/163 (11.0) 0.01
1/146 (0.7) 0.55 3/151 (2.0) 1/157 (0.6) 0.30 0/159 0.07
24/127 (18.9) 0.008 46/141 (32.6) 14/148 (9.5) <0.001 30/158 (19.0) 0.007
9/166 (5.4) 0.04 34/188 (18.1) ND 5/187 (2.7) <0.001
93/176 (52.8) 0.83 135/204 (66.2) 74/199 (37.2) <0.001 61/200 (30.5) <0.001
11/176 (6.2) 0.24 28/204 (13.7) 3/199 (1.5) <0.001 7/200 (3.5) <0.001
98/175 (56.0) 0.04 130/165 (78.8) 83/180 (46.1) <0.001 57/170 (33.5) <0.001
8/156 (5.1) <0.001 2/142 (1.4) 0/164 0.13 0/162 0.13
4/156 (2.6) 0.42 0/142 0/164 0/163
1/162 (0.6) 0.17 0/148 0/171 1/168 (0.6) 0.35
9/145 (6.2) 0.03 23/166 (13.9) 20/161 (12.4) 0.70 14/154 (9.1) 0.18
0/86 0.23 2/120 (1.7) 0/106 0.18 2/111 (1.8) 0.94
83/147 (56.5) 0.23 98/169 (58.0) 92/162 (56.8) 0.83 82/157 (52.2) 0.30
5/140 (3.6) 0.45 14/160 (8.8) 4/153 (2.6) 0.02 10/148 (6.8) 0.51
34/147 (23.1) 0.13 49/167 (29.3) 34/162 (21.0) 0.08 35/157 (22.3) 0.15
NA 3/154 (1.9) NA NA
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was nontyphoid salmonella, which was present in 38 of  the 
case patients (70.4%) and 11 of  the controls (78.6%) who 
had bacter mia (P=0.54). No mycobact ria were isola ed 
from any of  the specimens. Fever was absent in 36.8% of  
children wi h bacteremia. Am ng case patients, bacteremia
was less ommon in children with malaria than in those 
without alaria (21 of  208 [10.1%] vs. 32 of  150 [21.3%], 
P=0.003). Among control patients, bacteremia was also les  
common in children with malaria th n in those without (3 of  
146 [2.1%] vs. 11 of  207 [5 ], P=0.12).
Nutrition
Fifty-two case patients (15.8%) and 43 control patients 
(6.2%) had wasting; the attributable risk of  severe anemia 
associated with wasting was 6.2%. Severely anemic children 
were commonly stunted (53.2%) or underweight (49.2%), 
but for both conditions the unadjusted and adjusted odds 
ratios were similar to those for wasting (data not shown). 
Severe wasting occurred in 3.7% of  severely anemic children.
Vitamin B12 deficiency was found in 95 case patients (30.4%) 
and 94 controls (15.6%) and was severe (<13.6 ng per deciliter 
[100 pmol per liter]) in 11.2% of  case patients and 2.8% 
of  controls (adjusted odds ratio, 4.3; 95% CI, 1.9 to 9.9). 
Macrocytosis was more common in children with vitamin 
B12 deficiency than in children with normal vitamin B12 levels 
(P=0.02), although the sensitivity for vitamin B12 deficiency 
was low (17.5%). Severely anemic children with vitamin B12 
deficien y ate fewer meals with meat than those not deficient 
(1.9 vs. 2.7 per month, P=0 02 . Folate deficiency was not 
f und in any child enrolled in the study. Vitamin B12 and 
folate lev ls ere inversely correlated with each other among 
severely anemic children (Pearson correlation coefficient, 
−0.22; P=0.01).
Vitamin A deficiency was found in 92.3% of  case patients 
and 65.6% of  controls and was considered severe (less than 
10 μg per deciliter) in 32.8% of  case patients and 14.9% of  
controls (adjusted odds ratio, 1.6; 95% CI, 0.91 to 2.76). 
Vitamin A deficiency was associated with malaria and 
bacteremia in the structural equation model. Iron deficiency 
was found in 46.6% of  case patients and 69.4% of  controls. 
Further exploration indicated this finding was not affected 
by the definition used (Table 3). In the structural equation 
model, iron deficiency was found to be inversely associated 
with bacteremia (P=0.006).
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Hookworm
Hookworm was the most common helminth infection. 
Thirty-one (75.6%) of  the hookworm infections occurred in 
children less than 2 years old. The attributable risk of  severe 
anemia associated with hookworm in the rural site, where 
95.1% of  infections were seen, was 15.9%. In this site, 10.4% 
of  case patients and 0.6% of  controls had heavy infections 
(adjusted odds ratio, 9.4; 95% CI, 2.0 to 44.8). PCR was 
performed on 36 of  41 positive samples (87.8%). A. duodenale 
was found in 80.6% of  these samples, N. americanus in 8.3%, 
and a mixed infection in 11.1%. Hookworm infection was 
associated with iron deficiency (P=0.003) (Figure 2).
Sickle cell and G6PD variants
No association was found between severe anemia and sickle 
cell disease or between severe anemia and sickle cell trait 
(P=0.45 and P=0.20, respectively). Jaundice was uncommon 
in severely anemic children with sickle cell disease (0%) or 
G6PD−202/−376 (2.3%). Haptoglobin levels were commonly 
decreased (<0.30 g per liter) in case patients with G6PD−202/−376 
(78.4%). Boys accounted for 68.2% of  children with 
G6PD−202/−376, but after stratification, G6PD−202/−376 remained 
significantly associated with severe anemia in girls (adjusted 
odds ratio, 4.1; 95% CI, 1.2 to 13.3) and boys (adjusted odds 
ratio, 2.2; 95% CI, 1.1 to 4.7).
Discussion
In many African hospitals, severe anemia is a leading reason 
for admission and a major contributor to death. The cause 
of  the anemia has not been comprehensively investigated, 
but we found several important associations in this study.
Malaria is commonly considered to be a principal cause of  
severe anemia in Africa.7 In this study, P. falciparum parasitemia 
was strongly associated with severe anemia in the area with 
seasonal transmission but not in the area with holoendemic 
transmission. However, the cumulative effect of  malaria on 
an individual person is difficult to assess in holoendemic 
settings where children are repeatedly infected. Our findings 
therefore do not exclude malaria as a predisposing cause of  
severe anemia in the rural area but indicate that additional or 
alternative diagnoses should be considered in severely anemic 
children who receive a diagnosis of  malaria infection. In 
the structural equation model, malaria and bacteremia were 
identified as variables that modify the association between 
vitamin A deficiency and severe anemia. This is in line with 
earlier observations that vitamin A deficiency is associated 
with an increased susceptibility to infection.28 A vitamin A 
supplementation trial showed a reduction in the incidence of  
malaria,29 although this and another study failed to show that 
vitamin A supplementation reduced the incidence of  severe 
anemia.29,30
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with severe anemia were further explored in a 
multivariate and structural equation model (Fig. 1 
and 2).
Malaria
P. falciparum was identified in 226 case patients 
(59.5%) and 321 control patients (42.8%) and was 
the predominant malarial species overall (97.5%). 
P. malariae was found in 1.6% and a mixed infec-
tion in 0.9% of the study patients. The attributable 
risk of severe anemia associated with P. falciparum 
was 33.5% overall and 47.3% in the urban setting. 
In the rural setting, a significant association be-
tween malaria and severe anemia was found only 
in the subgroup of patients who had hyperparasit-
emia (9.7%) (adjusted odds ratio for case patients 
vs. community controls, 7.1; 95% confidence in-
terval [CI], 1.4 to 34.6).
HIV
HIV infection was found in 86 children (12.6% of 
case patients and 6.0% of controls). The attribut-
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Figure 1. Adjusted Odds Ratios and 95% Confidence Intervals for Factors Associated with Severe Anemia, According to Study Group  
and Recruitment Site.
The model was corrected for the possible confounders of age, sex, recent antimalarial treatment (within the previous 8 weeks), recent 
hematinic treatment (within the previous 8 weeks), a history of transfusion (before the previous 4 weeks), and death of a parent. The 
goodness of fit of the model was evaluated by the Hosmer–Lemeshow test (P = 0.65). In the combined model, interaction existed be-
tween malaria and site (P<0.001). Limited maternal education indicates mothers who did not attend secondary school. Wasting is de-
fined as a weight-for-height z score of less than −2. Concentrations of vitamin B12 of less than 20 ng per deciliter (148 pmol per liter) and 
of vitamin A of less than 20 μg per deciliter (0.7 μmol per liter) are considered to indicate deficiency. Iron deficiency is defined as a ratio 
of soluble transferrin receptor to log ferritin (TfR-F index)10 of more than 5.6 (unpublished data). Cultures to detect bacteremia were 
performed only in case patients and hospital controls. Hookworm infection was not entered in the urban model because the prevalence 
was less than 5%. The reference single-nucleotide polymorphism (rs) classification for IL10 +4949 is rs3024500.21 Because of the high 
correlation among the three interleukin-10 polymorphisms, only one (most strongly associated with severe anemia) was included in the 
multivariate model. HIV denotes human immunodeficiency virus, and G6PD−202/−376 denotes boys who are hemizygous and girls who 
are homozygous for both the G6PD202A and the G6PD376G alleles.
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We found an inverse association between iron deficiency and 
severe anemia. The structural equation model partly explains 
this finding by indicating that iron deficiency was inversely 
associated with bacteremia. This finding supports the 
hypothesis that iron deficiency protects against infection by 
creating an unfavorable environment for bacterial growth.31,32 
It is also in agreement with observations of  increased 
morbidity and mortality during iron-supplementation studies 
in areas where bacterial infections are common.32,33 Although 
iron supplementation may have a role in preventing anemia,33 
supplementation after severe anemia of  malaria had no 
hematologic benefits and resulted in increased morbidity in 
Tanzanian children.34
In rural children with severe anemia, we found an increased 
prevalence and intensity of  hookworm infections, with A. 
duodenale being the predominant species. Three quarters 
of  the hookworm-infected children were less than 2 years 
of  age. This age group would have remained untreated 
according to the current guidelines.7 Although hookworm 
is usually more frequent among older children, younger 
children might be more vulnerable to severe hematologic 
complications, especially in the presence of  heavy infections 
with A. duodenale.35
Bacteremia, most commonly due to nontyphoid salmonella, 
was strongly associated with severe anemia. This association 
has been described previously16,36,37 but is not reflected 
in current management guidelines for severe anemia in 
children.7 In the structural equation model, bacteremia was 
also identified as a mediating variable of  the effect of  HIV 
on severe anemia. Although bacteremia might not necessarily 
be a cause of  severe anemia, its high prevalence may justify 
antibiotic treatment in the standard management of  severe 
anemia in settings where HIV is prevalent and blood-culture 
facilities are not available.
Although folate supplementation is recommended by the 
WHO, folate deficiency was not found in our study groups. 
We may have underestimated its prevalence, because folate 
deficiency can be masked by vitamin B12 deficiency,
38 
and we measured plasma concentrations of  folate rather 
than erythrocyte concentrations. However, our findings 
concur with previous reports39 and observations that folate 
supplementation in anemic children with malaria failed to 
raise hemoglobin concentrations.40 Unlike folate, vitamin B12 
is not recommended in the management of  severe anemia. 
In our population, vitamin B12 deficiency was found in 30.4% 
of  case patients and was associated with severe anemia. This 
is in agreement with findings among adults in this region41,42 
and may be explained by the lack of  animal products in the 
diet of  Malawian children.
G6PD−202/−376 was found in 13.8% of  case patients and was 
associated with severe anemia, whereas sickle cell disease was 
uncommon in our study. The roles of  these mutations may 
be different in West and Central Africa. Possible associations 
of  interleukin-10 and tumor necrosis factor α with severe 
anemia of  malaria have been described,22,43 but in our study 
an imbalance in circulating plasma levels of  interleukin-10 
and tumor necrosis factor α was uncommon.
We found that several independent yet overlapping 
conditions are associated with severe anemia in Malawian 
children: bacteremia, malaria, hookworm, HIV infection, 
G6PD−202/−376, vitamin A deficiency, and vitamin B12 
deficiency. Our findings indicate that even in the presence 
of  malaria parasites, additional or alternative diagnoses 
should be considered. Current treatment recommendations 
that promote iron and folate supplements and ignore 
bacteremia, vitamin B12 deficiency, and, in young children, 
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able risk of severe anemia associated with HIV 
was 6.2% overall and 15.4% in the urban setting. 
Among severely anemic children, significantly 
more HIV-infected than HIV-uninfected children 
had Epstein–Barr virus infection (15 of 30 [50.0%] 
vs. 69 of 226 [30.5%], P = 0.03) or bacteremia (11 of 
42 [26.2%] vs. 38 of 300 [12.7%], P = 0.02), where-
as significantly fewer HIV-infected than HIV-unin-
fected children had hyperparasitemia (2 of 44 
[4.5%] vs. 42 of 312 [13.5%], P = 0.09) or vitamin 
B12 deficiency (5 of 39 [12.8%] vs. 85 of 254 [33.5%], 
P = 0.009).
Bacteremia
Fifty-four case patients (15.0%) and 14 controls 
(4.0%) had bacteremia. The attributable risk of se-
vere anemia associated with bacteremia was 12.2%. 
The most common pathogen was nontyphoid sal-
monella, which was present in 38 of the case pa-
tients (70.4%) and 11 of the controls (78.6%) who 
had bacteremia (P = 0.54). No mycobacteria were 
isolated from any of the specimens. Fever was ab-
sent in 36.8% of children with bacteremia. Among 
case patients, bacteremia was less common in chil-
dren with malaria than in those without malaria 
(21 of 208 [10.1%] vs. 32 of 150 [21.3%], P = 0.003). 
Among control patients, bacteremia was also less 
common in children with malaria than in those 
without (3 of 146 [2.1%] vs. 11 of 207 [5.3%], 
P = 0.12).
Nutrition
Fifty-two case patients (15.8%) and 43 control pa-
tients (6.2%) had wasting; the attributable risk of 
severe anemia associated with wasting was 6.2%. 
Severely anemic children were commonly stunted 
(53.2%) or underweight (49.2%), but for both con-
ditions the unadjusted and adjusted odds ratios 
were similar to those for wasting (data not 
shown). Severe wasting occurred in 3.7% of se-
verely anemic children. 
Vitamin B12 deficiency was found in 95 case 
patients (30.4%) and 94 controls (15.6%) and was 
severe (<13.6 ng per deciliter [100 pmol per liter]) 
33p9
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Figure 2. Structural Equation Model for Severe Anemia, Iron Deficiency, and Malaria.
In this exploratory model of the factors associated with severe anemia,25 the sizes of the associations are indicated 
by the standardized regression coefficients (range, −1.0 to +1.0). Inverse (protective) associations are indicated by 
red lines. This model was created containing all possible associations between the displayed variables, after which 
all nonsignificant arrows (P≥0.05) were removed. The model also contained all other variables entered in the multi-
variate model (omitted for clarity). The displayed variables were all adjusted for age; in addition, malaria was adjust-
ed for previous use of antimalarial agents, and iron deficiency was adjusted for a history of transfusions (before the 
previous 4 weeks) or use of hematinic agents (within the previous 8 weeks) (both omitted for clarity). Replacement 
of severe anemia by continuous hemoglobin levels and iron deficiency (ratio of soluble transferrin receptor to log 
ferritin, >5.6)10 resulted in a virtually identical mod l. The overall model fit was valid (root mean square area of ap-
proximation, 0.043; 95% confidence interval, 0.039 to 0.048). 
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10. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor 
and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 
1997;89:1052-7.
11. Bieri JG, Tolliver TJ, Catignani GL. Simultaneous determination of 
alpha-tocopherol and retinol in plasma or red cells by high pressure liquid 
chromatography. Am J Clin Nutr 1979;32:2143-9.
12. Sullivan AD, Ittarat I, Meshnick SR. Patterns of haemozoin accumulation in 
tissue. Parasitology 1996;112:285-94.
13. Katz N, Coelho PM, Pellegrino J. Evaluation of Kato’s quantitative method 
through the recovery of Schistosoma mansoni eggs added to human feces. J 
Parasitol 1970;56:1032-3.
14. de Gruijter JM, van Lieshout L, Gasser RB, et al. Polymerase chain 
reactionbased differential diagnosis of Ancylostoma duodenale and Necator 
americanus infections in humans in northern Ghana. Trop Med Int Health 
2005;10:574-80.
15. Shaker ZA, Hassan SI, el-Attar GM, et al. Use of Kato and nucleopore 
techniques for qualitative diagnosis of schistosomiasis. J Egypt Soc Parasitol 
1994;24:656-62.
16. Graham SM, Walsh AL, Molyneux EM, Phiri AJ, Molyneux ME. Clinical 
presentation of non-typhoidal Salmonella bacteraemia in Malawian children. 
Trans R Soc Trop Med Hyg 2000;94:310-4.
17. Boom R, Sol C, Beld M, Weel J, Goudsmit J, Wertheim-van Dillen P. 
Improved silica-guanidiniumthiocyanate DNA isolation procedure based on 
selective binding of bovine alpha-casein to silica particles. J Clin Microbiol 
1999;37:615-9.
18. Boom R, Sol C, Weel J, Gerrits Y, de Boer M, Wertheim-van Dillen P. A 
highly sensitive assay for detection and quantitation of human cytomegalovirus 
DNA in serum and plasma by PCR and electrochemiluminescence. J Clin 
Microbiol 1999;37:1489-97.
19. Koppelman MH, Cuypers HT, Emrich T, Zaaijer HL. Quantitative real-time 
detection of parvovirus B19 DNA in plasma. Transfusion 2004;44:97-103.
20. Molyneux EM, Tembo M, Kayira K, et al. The effect of HIV infection 
on paediatric bacterial meningitis in Blantyre, Malawi. Arch Dis Child 
2003;88:1112-8. [Erratum, Arch Dis Child 2004;89:395.]
21. Wilson JN, Rockett K, Jallow M, et al. Analysis of IL10 haplotypic 
associations with severe malaria. Genes Immun 2005;6:462-6.
22. May J, Lell B, Luty AJ, Meyer CG, Kremsner PG. Plasma interleukin-
10:Tumor necrosis factor (TNF)-alpha ratio is associated with TNF promoter 
hookworm infections appear to be of  limited applicability in 
our setting. Our findings, if  confirmed in different settings, 
will contribute to the assessment of  new therapeutic and 
preventive strategies for Africa.
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anemia of malaria had no hematologic benefits 
and resulted in increased morbidity in Tanzanian 
children.34
In rural children with seve e anemia, w  found 
an increased prevalence and intensity of hook-
worm infections, with A. duodenale being the pre-
domi ant species. Three quarters of the hook-
worm-infected children were less than 2 years of 
age. This ag  group would have remained un-
treated according to the current guidelines.7 Al-
though hookworm is usually more frequent among 
older children, you ger children might be more 
vul erable to s vere hematologic complications, 
especially in the presence of heavy infections with 
A. duodenale.35
Bacteremia, most commonly due to nontyphoid 
salmonella, was strongly associated with severe 
anemia. This association has been described 
previously16,36,37 but is n t reflected in current 
management guidelines for severe anemia in 
children.7 In the structural equation model, bac-
teremia was also identified as a mediating vari-
able of the effect of HIV on severe anemia. Al-
though bacteremia might not necessarily be a 
cause of severe anemia, its high prevalence may 
justify antibiotic treatment in the standard man-
agement of severe anemia in settings where HIV 
is prevalent and blood-culture facilities are not 
available.
Although folate supplementation is recom-
mended by the WHO, folate deficiency was not 
found in our study groups. We may have under-
estimated its prevalence, because folate deficiency 
can be masked by vitamin B12 deficiency,38 and 
we measured plasma co centrations f folate 
rather t an erythr cyte c ncentrations. How v-
er, our findings concur with previous reports39 
and observations that folate supplementation in 
anemic children with malaria failed to raise he-
moglobin concentrations.40 Unlike folate, vitamin 
B12 is not recommended in the management of 
severe anemia. In our population, vitamin B12 
deficiency was found in 30.4% of case patients 
and was associated with severe anemia. This is 
in agreement with findings among adults in this 
region41,42 and may be explained by the lack of 
animal products in the diet of Malawian children.
G6PD−202/−376 was found in 13.8% of case pa-
tients and was associated with severe anemia, 
whereas sickle cell isease was uncommon in ou  
study. The roles of these mutations may be differ-
ent in West and Central Africa. Possible associa-
tions of interleukin-10 and tumor necrosis factor α 
with severe anemia of malaria have been de-
Table 3. Prevalence of Iron Deficiency in Relation to the Development of Severe Anemia, According to Several 
Peripheral Blood Markers.*
Marker Prevalence Multivariate Analysis
Case Patients Control Patients Odds Ratio (95% CI)†
no./total no. (%)
TfR-F index‡ 97/208 (46.6) 288/415 (69.4) 0.37 (0.22–0.60)
Alternative definitions
CRP-containing index§ 35/208 (16.8) 212/415 (51.1) 0.29 (0.16–0.53)
Microcytosis¶ 48/316 (15.2) 182/636 (28.6) 0.47 (0.29–0.76)
Hypochromasia‖ 137/314 (43.6) 294/637 (46.2) 0.61 (0.41–0.91)
Microcytosis and hypochromasia 26/316 (8.2) 108/638 (16.9) 0.40 (0.22–0.72)
* Other markers that were assessed but not presented because they predicted iron deficiency less well (with sensitivity, 
specificity, or both under 40%) were ferritin, transferrin receptor, serum iron, serum transferrin, total iron-binding ca-
pacity, and transferrin saturation. CI denotes confidence interval, CRP C-reactive protein, and TfR-F index the ratio of 
soluble transferrin receptor to log ferritin.
† The odds ratios were obtained by replacing the original variable for iron deficiency in the multivariate analysis with the 
alternative definition.
‡ The original definition of iron deficiency was a TfR-F index greater than 5.6.
§ Iron deficiency is defined as a CRP-containing index (0.34 + 0.0043 × ferritin − [2.7 × TfR] ÷ ferritin + 0.0696 × CRP + 0.05 × TfR) 
of less than 0.26
¶ Microcytosis is defined as a mean corpuscular volume of less than 67 fl in children under 2 years of age and less than  
73 fl in children 2 to 5 years of age.27
‖ Hypochromasia is defined as a mean corpuscular hemoglobin concentration of less than 32 g per liter.27
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